Advanced MRI in Multiple Sclerosis: Current Status and Future Challenges

Neurologic Clinics

Volumn 29, Issue 2, 2011, Pages 357-380

  Fox, Robert J ^a,b   Beall, Erik ^c   Bhattacharyya, Pallab ^c   Chen, Jacqueline T ^d   Sakaie, Ken ^c  

^a NEUROLOGICAL INSTITUTE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^c Imaging Institute   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Diffusion tensor imaging; Functional MRI; Imaging; Magnetization transfer imaging; MRI; Spectroscopy

Indexed keywords

CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

BRAIN ATROPHY; DIAGNOSTIC IMAGING; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; IMAGE ANALYSIS; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REVIEW; TRACTOGRAPHY;

BRAIN; BRAIN MAPPING; DIAGNOSTIC IMAGING; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MULTIPLE SCLEROSIS; SPINAL CORD;

EID: 79952828577     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2010.12.011     Document Type: Review

References (167)

1. McDonald W.I., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121.
2. Trapp B.D., Peterson J., Ransohoff R.M., et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998, 338:278.
3. Bermel R.A., Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 2006, 5:158.
4. Fisher E., Rudick R.A., Simon J.H., et al. Eight-year follow-up study of brain atrophy in patients with MS. Neurology 2002, 59:1412.
5. Kappos L., Radue E.W., O'Connor P., et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 2010, 362:387.
6. Miller D.H., Soon D., Fernando K.T., et al. MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS. Neurology 2007, 68:1390.
7. Rudick R.A., Fisher E., Lee J.C., et al. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology 1999, 53:1698.
8. Zivadinov R., Reder A.T., Filippi M., et al. Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis. Neurology 2008, 71:136.
9. Duning T., Kloska S., Steinstrater O., et al. Dehydration confounds the assessment of brain atrophy. Neurology 2005, 64:548.
10. Altmann D.R., Jasperse B., Barkhof F., et al. Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis. Neurology 2009, 72:595.
11. Fisher E., Barkhof F., van den Elskamp I., et al. Comparion of brain atrophy measurement methods in the context of a clinical trial. Mult Scler 2009, 15:S217.
12. Schmierer K., Tozer D.J., Scaravilli F., et al. Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain. J Magn Reson Imaging 2007, 26:41.
13. Cercignani M., Basile B., Spano B., et al. Investigation of quantitative magnetisation transfer parameters of lesions and normal appearing white matter in multiple sclerosis. NMR Biomed 2009, 22:646.
14. Tozer D., Ramani A., Barker G.J., et al. Quantitative magnetization transfer mapping of bound protons in multiple sclerosis. Magn Reson Med 2003, 50:83.
15. Barkhof F., Bruck W., De Groot C.J., et al. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol 2003, 60(8):1073.
16. Schmierer K., Scaravilli F., Altmann D.R., et al. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004, 56:407.
17. Chen J.T., Kuhlmann T., Jansen G.H., et al. Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion. Neuroimage 2007, 36:1152.
18. Giacomini P.S., Levesque I.R., Ribeiro L., et al. Measuring demyelination and remyelination in acute multiple sclerosis lesion voxels. Arch Neurol 2009, 66:375.
19. Filippi M., Rocca M.A., Comi G. Magnetization transfer ratios of multiple sclerosis lesions with variable durations of enhancement. J Neurol Sci 1998, 159(2):162.
20. Pike G.B., De Stefano N., Narayanan S., et al. Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images. Radiology 2000, 215(3):824.
21. Richert N.D., Ostuni J.L., Bash C.N., et al. Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis. Mult Scler 2001, 7(1):49.
22. Filippi M., Rocca M.A., Sormani M.P., et al. Short-term evolution of individual enhancing MS lesions studied with magnetization transfer imaging. Magn Reson Imaging 1999, 17:979.
23. Lai H.M., Davie C.A., Gass A., et al. Serial magnetisation transfer ratios in gadolinium-enhancing lesions in multiple sclerosis. J Neurol 1997, 244(5):308.
24. Silver N., Lai M., Symms M., et al. Serial gadolinium-enhanced and magnetization transfer imaging to investigate the relationship between the duration of blood-brain barrier disruption and extent of demyelination in new multiple sclerosis lesions. J Neurol 1999, 246:728.
25. van Waesberghe J.H., van Walderveen M.A., Castelijns J.A., et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am J Neuroradiol 1998, 19:675.
26. Dousset V., Gayou A., Brochet B., et al. Early structural changes in acute MS lesions assessed by serial magnetization transfer studies. Neurology 1998, 51:1150.
27. Bruck W., Schmied M., Suchanek G., et al. Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol 1994, 35:65.
28. Chen J.T., Collins D.L., Atkins H.L., et al. Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions. Ann Neurol 2008, 63:254.
29. Prineas J.W., Connell F. Remyelination in multiple sclerosis. Ann Neurol 1979, 5:22.
30. De Stefano N., Battaglini M., Stromillo M.L., et al. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis. Brain 2006, 129:2008.
31. Ramio-Torrenta L., Sastre-Garriga J., Ingle G.T., et al. Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study. J Neurol Neurosurg Psychiatry 2006, 77:40.
32. Filippi M., Tortorella C., Rovaris M., et al. Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000, 68:157.
33. Khaleeli Z., Cercignani M., Audoin B., et al. Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability. Neuroimage 2007, 37:253.
34. Amato M.P., Portaccio E., Stromillo M.L., et al. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Neurology 2008, 71:632.
35. Santos A.C., Narayanan S., de Stefano N., et al. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis. J Neurol 2002, 249:662.
36. Khaleeli Z., Altmann D.R., Cercignani M., et al. Magnetization transfer ratio in gray matter: a potential surrogate marker for progression in early primary progressive multiple sclerosis. Arch Neurol 2008, 65:1454.
37. Bozzali M., Rocca M.A., Iannucci G., et al. Magnetization-transfer histogram analysis of the cervical cord in patients with multiple sclerosis. AJNR Am J Neuroradiol 1999, 20:1803.
38. Zackowski K.M., Smith S.A., Reich D.S., et al. Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cord. Brain 2009, 132:1200.
39. Dwyer M., Bergsland N., Hussein S., et al. A sensitive, noise-resistant method for identifying focal demyelination and remyelination in patients with multiple sclerosis via voxel-wise changes in magnetization transfer ratio. J Neurol Sci 2009, 282:86.
40. Arnold D.L., Dalton C.M., Narayanan S., et al. Magnetization transfer ratio imaging is feasible in large multicenter MS trials. Neurology 2010, 74:A118.
41. Calabrese M., Rocca M.A., Atzori M., et al. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Ann Neurol 2010, 67:376.
42. Geurts J.J., Pouwels P.J., Uitdehaag B.M., et al. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 2005, 236:254.
43. Simon B., Schmidt S., Lukas C., et al. Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. Eur Radiol 2010, 20(7):1675-1683.
44. Bagnato F., Butman J.A., Gupta S., et al. In vivo detection of cortical plaques by MR imaging in patients with multiple sclerosis. AJNR Am J Neuroradiol 2006, 27:2161.
45. Nelson F., Poonawalla A.H., Hou P., et al. Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. AJNR Am J Neuroradiol 2007, 28:1645.
46. Nelson F., Poonawalla A., Hou P., et al. 3D MPRAGE improves classification of cortical lesions in multiple sclerosis. Mult Scler 2008, 14:1214.
47. Bagnato F., Yao B., Cantor F., et al. Multisequence-imaging protocols to detect cortical lesions of patients with multiple sclerosis: observations from a post-mortem 3 Tesla imaging study. J Neurol Sci 2009, 282:80.
48. Stejskal E., Tanner J. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J Chem Phys 1965, 42:288.
49. Moseley M.E., Cohen Y., Mintorovitch J., et al. Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy. Magn Reson Med 1990, 14:330.
50. Jones D.K. The effect of gradient sampling schemes on measures derived from diffusion tensor MRI: a Monte Carlo study. Magn Reson Med 2004, 51:807.
51. Feng S., Hong Y., Zhou Z., et al. Monitoring of acute axonal injury in the swine spinal cord with EAE by diffusion tensor imaging. J Magn Reson Imaging 2009, 30:277.
52. Kim J.H., Budde M.D., Liang H.F., et al. Detecting axon damage in spinal cord from a mouse model of multiple sclerosis. Neurobiol Dis 2006, 21:626.
53. Budde M.D., Kim J.H., Liang H.F., et al. Toward accurate diagnosis of white matter pathology using diffusion tensor imaging. Magn Reson Med 2007, 57:688.
54. DeBoy C.A., Zhang J., Dike S., et al. High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord. Brain 2007, 130:2199.
55. Ciccarelli O., Werring D.J., Barker G.J., et al. A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging-evidence of Wallerian degeneration. J Neurol 2003, 250:287.
56. Yu C.S., Lin F.C., Li K.C., et al. Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica. AJNR Am J Neuroradiol 2006, 27:1009.
57. Song S.K., Yoshino J., Le T.Q., et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 2005, 26:132.
58. Simon J.H., Zhang S., Laidlaw D.H., et al. Identification of fibers at risk for degeneration by diffusion tractography in patients at high risk for MS after a clinically isolated syndrome. J Magn Reson Imaging 2006, 24:983.
59. Basser P.J., Pajevic S., Pierpaoli C., et al. In vivo fiber tractography using DT-MRI data. Magn Reson Med 2000, 44(4):625.
60. Mori S., Crain B., Chacko V., et al. Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol 1999, 45:265.
61. Behrens T.E., Berg H.J., Jbabdi S., et al. Probabilistic diffusion tractography with multiple fibre orientations: what can we gain?. Neuroimage 2007, 34:144.
62. Jian B., Vemuri B.C. Multi-fiber reconstruction from diffusion MRI using mixture of Wisharts and sparse deconvolution. Inf Process Med Imaging 2007, 20:384.
63. Ozarslan E., Shepherd T.M., Vemuri B.C., et al. Resolution of complex tissue microarchitecture using the diffusion orientation transform (DOT). Neuroimage 2006, 31:1086.
64. Tuch D.S. Q-ball imaging. Magn Reson Med 2004, 52:1358.
65. Kreher B.W., Mader I., Kiselev V.G. Gibbs tracking: a novel approach for the reconstruction of neuronal pathways. Magn Reson Med 2008, 60:953.
66. Staempfli P., Jaermann T., Crelier G.R., et al. Resolving fiber crossing using advanced fast marching tractography based on diffusion tensor imaging. Neuroimage 2006, 30:110.
67. Lowe M.J., Horenstein C., Hirsch J.G., et al. Functional pathway-defined MRI diffusion measures reveal increased transverse diffusivity of water in multiple sclerosis. Neuroimage 2006, 32:1127.
68. Heiervang E., Behrens T.E., Mackay C.E., et al. Between session reproducibility and between subject variability of diffusion MR and tractography measures. Neuroimage 2006, 33:867.
69. Smith S.M., Jenkinson M., Johansen-Berg H., et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006, 31:1487.
70. Dineen R.A., Vilisaar J., Hlinka J., et al. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 2009, 132:239.
71. Giorgio A., Palace J., Johansen-Berg H., et al. Relationships of brain white matter microstructure with clinical and MR measures in relapsing-remitting multiple sclerosis. J Magn Reson Imaging 2010, 31:309.
72. Filippi M., Cercignani M., Inglese M., et al. Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology 2001, 56:304.
73. Ge Y., Law M., Johnson G., et al. Preferential occult injury of corpus callosum in multiple sclerosis measured by diffusion tensor imaging. J Magn Reson Imaging 2004, 20:1.
74. Naismith R.T., Xu J., Tutlam N.T., et al. Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole. Neurology 2010, 74:1694.
75. Werring D.J., Clark C.A., Barker G.J., et al. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology 1999, 52(8):1626.
76. Shukla D.K., Kaiser C.C., Stebbins G.T., et al. Effects of pioglitazone on diffusion tensor imaging indices in multiple sclerosis patients. Neurosci Lett 2010, 472:153.
77. Sijens P.E., Mostert J.P., Irwan R., et al. Impact of fluoxetine on the human brain in multiple sclerosis as quantified by proton magnetic resonance spectroscopy and diffusion tensor imaging. Psychiatry Res 2008, 164:274.
78. Fox R.J., McColl R.W., Lee J.C., et al. A preliminary validation study of diffusion tensor imaging as a measure of functional brain injury. Arch Neurol 2008, 65:1179.
79. Reich D.S., Zackowski K.M., Gordon-Lipkin E.M., et al. Corticospinal tract abnormalities are associated with weakness in multiple sclerosis. AJNR Am J Neuroradiol 2008, 29:333.
80. Wedeen V.J., Hagmann P., Tseng W.Y., et al. Mapping complex tissue architecture with diffusion spectrum magnetic resonance imaging. Magn Reson Med 2005, 54:1377.
81. Assaf Y., Ben-Bashat D., Chapman J., et al. High b-value q-space analyzed diffusion-weighted MRI: application to multiple sclerosis. Magn Reson Med 2002, 47:115.
82. Mulkern R.V., Gudbjartsson H., Westin C.F., et al. Multi-component apparent diffusion coefficients in human brain. NMR Biomed 1999, 12:51.
83. Jensen J.H., Helpern J.A., Ramani A., et al. Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med 2005, 53:1432.
84. Fox R.J. Picturing multiple sclerosis: conventional and diffusion tensor imaging. Semin Neurol 2008, 28:453.
85. de Graaf R.A. In vivo NMR spectroscopy Principles and techniques 1998, John Wiley & Sons, New York.
86. Govindaraju V., Young K., Maudsley A.A. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 2000, 13:129.
87. Sajja B.R., Wolinsky J.S., Narayana P.A. Proton magnetic resonance spectroscopy in multiple sclerosis. Neuroimaging Clin N Am 2009, 19:45.
88. Davie C.A., Barker G.J., Thompson A.J., et al. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. J Neurol Neurosurg Psychiatry 1997, 63:736.
89. Arnold D.L., Matthews P.M., Francis G., et al. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn Reson Med 1990, 14:154.
90. Narayana P.A., Doyle T.J., Lai D., et al. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 1998, 43:56.
91. Kapeller P., McLean M.A., Griffin C.M., et al. Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study. J Neurol 2001, 248:131.
92. Chard D.T., Griffin C.M., McLean M.A., et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain 2002, 125:2342.
93. Gonen O., Catalaa I., Babb J.S., et al. Total brain N-acetylaspartate: a new measure of disease load in MS. Neurology 2000, 54:15.
94. Tiberio M., Chard D.T., Altmann D.R., et al. Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study. J Neurol 2006, 253:224.
95. Leary S.M., Davie C.A., Parker G.J., et al. 1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis. J Neurol 1999, 246:1023.
96. He J., Inglese M., Li B.S., et al. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience. Radiology 2005, 234:211.
97. Inglese M., Li B.S., Rusinek H., et al. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis. Magn Reson Med 2003, 50:190.
98. Larsson H.B., Christiansen P., Jensen M., et al. Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis. Magn Reson Med 1991, 22:23.
99. Arnold D.L., Matthews P.M., Francis G.S., et al. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol 1992, 31:235.
100. Tartaglia M.C., Narayanan S., De Stefano N., et al. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. J Neurol 2002, 249:1382.
101. Srinivasan R., Sailasuta N., Hurd R., et al. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 2005, 128:1016.
102. De Stefano N., Matthews P.M., Antel J.P., et al. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 1995, 38:901.
103. Fernando K.T., McLean M.A., Chard D.T., et al. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2004, 127:1361.
104. Mader I., Seeger U., Weissert R., et al. Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis. Brain 2001, 124:953.
105. Davie C.A., Hawkins C.P., Barker G.J., et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994, 117(Pt 1):49.
106. Narayana P.A., Wolinsky J.S., Rao S.B., et al. Multicentre proton magnetic resonance spectroscopy imaging of primary progressive multiple sclerosis. Mult Scler 2004, 10(Suppl 1):S73.
107. Bastianello S., Paolillo A., Giugni E., et al. MRI of spinal cord in MS. J Neurovirol 2000, 6(Suppl 2):S130.
108. Tartaglino L.M., Friedman D.P., Flanders A.E., et al. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 1995, 195:725.
109. Marliani A.F., Clementi V., Albini-Riccioli L., et al. Quantitative proton magnetic resonance spectroscopy of the human cervical spinal cord at 3 Tesla. Magn Reson Med 2007, 57:160.
110. Kendi A.T., Tan F.U., Kendi M., et al. MR spectroscopy of cervical spinal cord in patients with multiple sclerosis. Neuroradiology 2004, 46:764.
111. Ciccarelli O., Wheeler-Kingshott C.A., McLean M.A., et al. Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. Brain 2007, 130:2220.
112. Brownell B., Hughes J.T. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962, 25:315.
113. Kidd D., Barkhof F., McConnell R., et al. Cortical lesions in multiple sclerosis. Brain 1999, 122(Pt 1):17.
114. Choi I.Y., Lee S.P., Merkle H., et al. In vivo detection of gray and white matter differences in GABA concentration in the human brain. Neuroimage 2006, 33:85.
115. Petroff O.A., Pleban L.A., Spencer D.D. Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain. Magn Reson Imaging 1995, 13:1197.
116. Dutta R., McDonough J., Yin X., et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 2006, 59:478.
117. Bhattacharyya P., Phillips M., Bermel R., et al. Impaired motor performance in MS is associated with increased GABA level in sensorimotor cortex. Proc Int Soc Magn Reson Med 2010, 18:390.
118. Kreis R. Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts. NMR Biomed 2004, 17:361.
119. Bhattacharyya P.K., Lowe M.J., Phillips M.D. Spectral quality control in motion-corrupted single-voxel J-difference editing scans: an interleaved navigator approach. Magn Reson Med 2007, 58:808.
120. Felblinger J., Kreis R., Boesch C. Effects of physiologic motion of the human brain upon quantitative 1H-MRS: analysis and correction by retro-gating. NMR Biomed 1998, 11:107.
121. Posse S., Cuenod C.A., Le Bihan D. Human brain: proton diffusion MR spectroscopy. Radiology 1993, 188:719.
122. Ziegler A., Decorp M. Signal-to-noise improvement in in-vivo spin-echo spectroscopy in the presence of motion. J Magn Reson 1993, 102:26.
123. Buxton R.B., Uludag K., Dubowitz D.J., et al. Modeling the hemodynamic response to brain activation. Neuroimage 2004, 23(Suppl 1):S220.
124. Logothetis N.K., Pauls J., Augath M., et al. Neurophysiological investigation of the basis of the fMRI signal. Nature 2001, 412:150.
125. Kwong K.K., Belliveau J.W., Chesler D.A., et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci U S A 1992, 89:5675.
126. Ogawa S., Lee T.M., Kay A.R., et al. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A 1990, 87:9868.
127. Biswal B., Yetkin F.Z., Haughton V.M., et al. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 1995, 34:537.
128. Lowe M.J., Mock B.J., Sorenson J.A. Functional connectivity in single and multislice echoplanar imaging using resting-state fluctuations. Neuroimage 1998, 7:119.
129. Miki A., Nakajima T., Fujita M., et al. Functional magnetic resonance imaging of the primary visual cortex: evaluation of human afferent visual system. Jpn J Ophthalmol 1995, 39:302.
130. Yousry T.A., Berry I., Filippi M. Functional magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998, 64(Suppl 1):S85.
131. Gareau P.J., Gati J.S., Menon R.S., et al. Reduced visual evoked responses in multiple sclerosis patients with optic neuritis: comparison of functional magnetic resonance imaging and visual evoked potentials. Mult Scler 1999, 5:161.
132. Audoin B., Ibarrola D., Ranjeva J.P., et al. Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of MS. Hum Brain Mapp 2003, 20:51.
133. Staffen W., Mair A., Zauner H., et al. Cognitive function and fMRI in patients with multiple sclerosis: evidence for compensatory cortical activation during an attention task. Brain 2002, 125:1275.
134. Hillary F.G., Chiaravalloti N.D., Ricker J.H., et al. An investigation of working memory rehearsal in multiple sclerosis using fMRI. J Clin Exp Neuropsychol 2003, 25:965.
135. Parry A.M., Scott R.B., Palace J., et al. Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine. Brain 2003, 126:2750.
136. Penner I.K., Rausch M., Kappos L., et al. Analysis of impairment related functional architecture in MS patients during performance of different attention tasks. J Neurol 2003, 250:461.
137. Sweet L.H., Rao S.M., Primeau M., et al. Functional magnetic resonance imaging of working memory among multiple sclerosis patients. J Neuroimaging 2004, 14:150.
138. Lee M., Reddy H., Johansen-Berg H., et al. The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis. Ann Neurol 2000, 47:606.
139. Reddy H., Narayanan S., Arnoutelis R., et al. Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. Brain 2000, 123(Pt 11):2314.
140. Reddy H., Narayanan S., Woolrich M., et al. Functional brain reorganization for hand movement in patients with multiple sclerosis: defining distinct effects of injury and disability. Brain 2002, 125:2646.
141. Rocca M.A., Matthews P.M., Caputo D., et al. Evidence for widespread movement-associated functional MRI changes in patients with PPMS. Neurology 2002, 58:866.
142. Filippi M., Rocca M.A., Mezzapesa D.M., et al. A functional MRI study of cortical activations associated with object manipulation in patients with MS. Neuroimage 2004, 21:1147.
143. Ciccarelli O., Toosy A.T., Marsden J.F., et al. Functional response to active and passive ankle movements with clinical correlations in patients with primary progressive multiple sclerosis. J Neurol 2006, 253:882.
144. Rocca M.A., Filippi M. Functional MRI in multiple sclerosis. J Neuroimaging 2007, 17(Suppl 1):36S.
145. Buckle G.J. Functional magnetic resonance imaging and multiple sclerosis: the evidence for neuronal plasticity. J Neuroimaging 2005, 15:82S.
146. Pantano P., Mainero C., Lenzi D., et al. A longitudinal fMRI study on motor activity in patients with multiple sclerosis. Brain 2005, 128:2146.
147. Korsholm K., Madsen K.H., Frederiksen J.L., et al. Recovery from optic neuritis: an ROI-based analysis of LGN and visual cortical areas. Brain 2007, 130:1244.
148. Audoin B., Reuter F., Duong M.V., et al. Efficiency of cognitive control recruitment in the very early stage of multiple sclerosis: a one-year fMRI follow-up study. Mult Scler 2008, 14:786.
149. Cardinal K.S., Wilson S.M., Giesser B.S., et al. A longitudinal fMRI study of the paced auditory serial addition task. Mult Scler 2008, 14:465.
150. Morgen K., Kadom N., Sawaki L., et al. Training-dependent plasticity in patients with multiple sclerosis. Brain 2004, 127:2506.
151. Cader S., Palace J., Matthews P.M. Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis. J Psychopharmacol 2009, 23:686.
152. Pelletier J., Audoin B., Reuter F., et al. Plasticity in MS: from functional imaging to rehabilitation. Int MS J 2009, 16:26.
153. Filippi M., Rocca M.A., Colombo B., et al. Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage 2002, 15:559.
154. DeLuca J., Genova H.M., Hillary F.G., et al. Neural correlates of cognitive fatigue in multiple sclerosis using functional MRI. J Neurol Sci 2008, 270:28.
155. Tartaglia M.C., Narayanan S., Arnold D.L. Mental fatigue alters the pattern and increases the volume of cerebral activation required for a motor task in multiple sclerosis patients with fatigue. Eur J Neurol 2008, 15:413.
156. White A.T., Lee J.N., Light A.R., et al. Brain activation in multiple sclerosis: a BOLD fMRI study of the effects of fatiguing hand exercise. Mult Scler 2009, 15:580.
157. Mainero C., Caramia F., Pozzilli C., et al. fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis. Neuroimage 2004, 21:858.
158. Rocca M.A., Gallo A., Colombo B., et al. Pyramidal tract lesions and movement-associated cortical recruitment in patients with MS. Neuroimage 2004, 23:141.
159. Lenzi D., Conte A., Mainero C., et al. Effect of corpus callosum damage on ipsilateral motor activation in patients with multiple sclerosis: a functional and anatomical study. Hum Brain Mapp 2007, 28:636.
160. Bonzano L., Pardini M., Mancardi G.L., et al. Structural connectivity influences brain activation during PVSAT in Multiple Sclerosis. Neuroimage 2009, 44:9.
161. Lowe M.J., Beall E.B., Sakaie K.E., et al. Resting state sensorimotor functional connectivity in multiple sclerosis inversely correlates with transcallosal motor pathway transverse diffusivity. Hum Brain Mapp 2008, 29:818.
162. Mainero C., Pantano P., Caramia F., et al. Brain reorganization during attention and memory tasks in multiple sclerosis: insights from functional MRI studies. J Neurol Sci 2006, 245:93.
163. Ingle G.T., Thompson A.J., Miller D.H. Magnetic resonance imaging in primary progressive multiple sclerosis. J Rehabil Res Dev 2002, 39:261.
164. Iannetti G.D., Wise R.G. BOLD functional MRI in disease and pharmacological studies: room for improvement?. Magn Reson Imaging 2007, 25:978.
165. Bullmore E.T., Brammer M.J., Rabe-Hesketh S., et al. Methods for diagnosis and treatment of stimulus-correlated motion in generic brain activation studies using fMRI. Hum Brain Mapp 1999, 7:38.
166. Bhattacharyya P.K., Lowe M.J. Cardiac-induced physiologic noise in tissue is a direct observation of cardiac-induced fluctuations. Magn Reson Imaging 2004, 22:9.
167. Lund T.E., Madsen K.H., Sidaros K., et al. Non-white noise in fMRI: does modelling have an impact?. Neuroimage 2006, 29:54.